STOCK TITAN

ORIC (NASDAQ: ORIC) holder files notice to sell 7,000 shares of stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ORIC Pharmaceuticals filed a notice that a shareholder plans to sell 7,000 shares of common stock through J.P. Morgan Securities LLC on Nasdaq, with an aggregate market value of $84,000. The filing lists 97,389,279 shares of common stock outstanding. The shares to be sold were acquired on 08/25/2016 by exercising stock options for cash on that same date.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ORIC's Form 144 filing disclose?

It discloses that a shareholder plans to sell 7,000 shares of ORIC common stock through J.P. Morgan Securities LLC on the Nasdaq exchange, with an aggregate market value of $84,000.

How many ORIC shares are planned to be sold under this Form 144?

The notice covers a planned sale of 7,000 shares of ORIC common stock.

What is the aggregate market value of the ORIC shares to be sold?

The aggregate market value of the 7,000 ORIC common shares to be sold is listed as $84,000.

When were the ORIC shares to be sold originally acquired?

The 7,000 shares were acquired on 08/25/2016 through a stock option exercise paid in cash.

How many ORIC shares are shown as outstanding in this filing?

The filing lists 97,389,279 shares of ORIC common stock as outstanding.

On which exchange will the ORIC shares be sold and through which broker?

The planned sale is through J.P. Morgan Securities LLC on the Nasdaq exchange.
Oric Pharmaceuticals, Inc.

NASDAQ:ORIC

ORIC Rankings

ORIC Latest News

ORIC Latest SEC Filings

ORIC Stock Data

1.18B
87.10M
6.94%
99.21%
8.42%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO